BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IMC-003 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of IMC-003\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07118085-566@assetmemo.bio
DTSTAMP:20261121T004548Z
DTSTART;VALUE=DATE:20270520
DTEND;VALUE=DATE:20270521
SUMMARY:IMC-003: Phase 1 readout est. (NCT07118085)
DESCRIPTION:IMC-003\, phase 1.\nStudy: A Randomized\, Double-blind\, Placeb
 o-controlled\, Single and Multiple Dose Escalation Phase I Clinical Trial 
 to Evaluate the Safety\, Tolerability\, Pharmacokinetics and Pharmacodynam
 ics of IMC-003 for Injection in Healthy Postmenopausal Women\nEstimated pr
 imary completion: 20 May 2027. This is a ClinicalTrials.gov estimate\, not
  a confirmed readout date\, and it can move.\nDrug page: https://assetmemo
 .bio/drug/imc-003#upcoming-events\nRegistry record: https://clinicaltrials
 .gov/study/NCT07118085
URL:https://assetmemo.bio/drug/imc-003#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07593027-566@assetmemo.bio
DTSTAMP:20261121T004548Z
DTSTART;VALUE=DATE:20271031
DTEND;VALUE=DATE:20271101
SUMMARY:IMC-003: Phase 1/2 readout est. (NCT07593027)
DESCRIPTION:IMC-003\, phase 1/2.\nStudy: A Phase Ⅰb/Ⅱa Clinical Study o
 f IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension R
 eceiving Background Therapy.\nEstimated primary completion: 31 October 202
 7. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, 
 and it can move.\nDrug page: https://assetmemo.bio/drug/imc-003#upcoming-e
 vents\nRegistry record: https://clinicaltrials.gov/study/NCT07593027
URL:https://assetmemo.bio/drug/imc-003#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
